Evaluation of a novel photoactive and biotinylated dehydroepiandrosterone analog

Molecular and Cellular Endocrinology

Volumn 328, Issue 1-2, 2010, Pages 56-62

  Liu, Dongmin ^a,b   O'Leary, Brianne ^a   Iruthayanathan, Mary ^a,b   Love Homan, Laurie ^b   Perez Hernandez, Nury ^c   Olivo, Horacio F ^c   Dillon, Joseph S ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Benzophenone; Biotin; DHEA; Nitric oxide; Non genomic

Indexed keywords

AGAROSE; AVIDIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PRASTERONE; PRASTERONE BENZOPHENONE BIOTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BIOTINYLATION; CELL CULTURE; CELL MEMBRANE; CELL SURFACE; CHEMOLUMINESCENCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; COW; CROSS LINKING; DRUG BINDING; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENDOTHELIUM CELL; MEMBRANE BINDING; NONHUMAN; PHOTOREACTIVITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

ANDROSTERONE; ANIMALS; BENZOPHENONES; BIOTIN; BIOTINYLATION; CATTLE; CELL MEMBRANE; CELLS, CULTURED; CHEMILUMINESCENT MEASUREMENTS; DEHYDROEPIANDROSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; PHOTOAFFINITY LABELS; PHOTOSENSITIZING AGENTS; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

EID: 77956338888     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.07.002     Document Type: Article

References (38)

1. Adams A., Pines M., Nakamoto C., Behar V., Yang Q., Bessalle R., Chorev M., Rosenblatt M., Levine M., Suva L. Probing the bimolecular interactions of parathyroid hormone and the human parathyroid hormone parathyroid hormone-related protein receptor. Biochemistry 1995, 34:10553-10559.
2. Alexaki V.I., Charalampopoulos I., Panayotopoulou M., Kampa M., Gravanis A., Castanas E. Dehydroepiandrosterone protects human keratinocytes against apoptosis through membrane binding sites. Exp. Cell Res. 2009, 315:2275-2283.
3. Alexandersen P., Haarbo J., Christiansen C. The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis 1996, 125:1-13.
4. Banerjee S., Selim H., Suliman G., Geller A., Juppner H., Bringhurst F., Divieti P. Synthesis and characterization of novel biotinylated carboxyl-terminal parathyroid hormone peptides that specifically crosslink to the CPTH-receptor. Peptides 2006, 27:3352-3362.
5. Benten W., Guo Z., Krücken J., Wunderlich F. Rapid effects of androgens in macrophages. Steroids 2004, 69:585-590.
6. Brennan D., Levine M. Characterization of soluble and particulate parathyroid hormone receptors using a biotinylated bioactive hormone analog. J. Biol. Chem. 1987, 262:14795-14800.
7. Charalampopoulos I., Alexaki V.I., Lazaridis I., Dermitzaki E., Avlonitis N., Tsatsanis C., Calogeropoulou T., Margioris A.N., Castanas E., Gravanis A. G protein-associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone. FASEB J. 2006, 20:577-579.
8. Charalampopoulos I., Tsatsanis C., Dermitzaki E., Alexaki V.I., Castanas E., Margioris A.N., Gravanis A. Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8209-8214.
9. Chen F., Knecht K., Birzin E., Fisher J., Wilkinson H., Mojena M., Moreno C.T., Schmidt A., Harada S., Freedman L.P., Reszka A.A. Direct agonist/antagonist functions of dehydroepiandrosterone. Endocrinology 2005, 146:4568-4576.
10. Chen H., Lin A.S., Li Y., Reiter C.E., Ver M.R., Quon M.J. Dehydroepiandrosterone stimulates phosphorylation of FoxO1 in vascular endothelial cells via phosphatidylinositol 3-kinase- and protein kinase A-dependent signaling pathways to regulate ET-1 synthesis and secretion. J. Biol. Chem. 2008, 283:29228-29238.
11. Dorman G., Prestwich G. Benzophenone photophores in biochemistry. Biochemistry 1994, 33:5661-5673.
12. Feldman H.A., Johannes C.B., Araujo A.B., Mohr B.A., Longcope C., McKinlay J.B. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study. Am. J. Epidemiol. 2001, 153:79-89.
13. Formoso G., Chen H., Kim J.A., Montagnani M., Consoli A., Quon M.J. Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1 via distinct phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-dependent pathways in vascular endothelium. Mol. Endocrinol. 2006, 20:1153-1163.
14. Hannon J., Nunn C., Stolz B., Bruns C., Weckbecker G., Lewis I., Troxler T., Hurth K., Hoyer D. Drug design at peptide receptors: somatostatin receptor ligands. J. Mol. Neurosci. 2002, 18:15-27.
15. Hauptmann H., Paulus B., Kaiser T., Herdtweck E., Huber E., Luppa P.B. Concepts for the syntheses of biotinylated steroids. Part I: testosterone derivatives as immunochemical probes. Bioconjug. Chem. 2000, 11:239-252.
16. Hazum E. Purification of gonadotropin releasing hormone receptors using the avidin-biotin technique. J. Chromatogr. 1990, 510:233-238.
17. Hein L., Meinel L., Pratt R., Dzau V., Kobilka B. Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol. Endocrinol. 1997, 11:1266-1277.
18. Herrington D.M., Gordon G.B., Achuff S.C., Trejo J.F., Weisman H.F., Kwiterovich P.O., Pearson T.A. Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J. Am. Coll. Cardiol. 1990, 16:862-870.
19. Hussey S., Muddana S., Peterson B. Synthesis of a beta-estradiol-biotin chimera that potently heterodimerizes estrogen receptor and streptavidin proteins in a yeast three-hybrid system. J. Am. Chem. Soc. 2003, 125:3692-3693.
20. Kohanski R.A., Lane M.D. Homogeneous functional insulin receptor from 3T3-L1 adipocytes. Purification using N alpha B1-(biotinyl-epsilon-aminocaproyl)insulin and avidin-sepharose. J. Biol. Chem. 1985, 260:5014-5025.
21. Laurine E., Lafitte D., Gregoire C., Seree E., Loret E., Douillard S., Michel B., Briand C., Verdier J.M. Specific binding of dehydroepiandrosterone to the N terminus of the microtubule-associated protein MAP2. J. Biol. Chem. 2003, 278:29979-29986.
22. Lemcke S., Hönnscheidt C., Waschatko G., Bopp A., Lütjohann D., Bertram N., Gehrig-Burger K. DHEA-Bodipy-a functional fluorescent DHEA analog for live cell imaging. Mol. Cell. Endocrinol. 2010, 314:31-40.
23. Liu D., Dillon J.S. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). J. Biol. Chem. 2002, 277:21379-21388.
24. Liu D., Dillon J.S. Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor. Steroids 2004, 69:279-289.
25. Liu D., Iruthayanathan M., Homan L.L., Wang Y., Yang L., Wang Y., Dillon J.S. Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanisms. Endocrinology 2008, 149:889-898.
26. Manz B., Heubner A., Kohler I., Grill H.J., Pollow K. Synthesis of biotin-labelled dexamethasone derivatives. Novel hormone-affinity probes. Eur. J. Biochem. 1983, 131:333-338.
27. McLatchie L., Fraser N., Main M., Wise A., Brown J., Thompson N., Solari R., Lee M., Foord S. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998, 393:333-339.
28. Newman W., Beall L.D., Bertolini D.R., Cone J.L. Modulation of TGF-beta type 1 receptor: flow cytometric detection with biotinylated TGF-beta. J. Cell Physiol. 1989, 141:170-180.
29. Okamoto K. Relationship between dehydroepiandrosterone sulfate and serum lipid levels in Japanese men. J. Epidemiol. 1996, 6:63-67.
30. Olivo H., Perez-Hernandez N., Liu D., Iruthayanathan M., O'Leary B., Homan L., Dillon J.S. Synthesis and application of a photoaffinity analog of dehydroepiandrosterone (DHEA). Bioorg. Med. Chem. Lett. 2010, 20:1153-1155.
31. Radford D.J., Wang K., McNelis J.C., Taylor A.E., Hechenberger G., Hofmann J., Chahal H., Arlt W., Lord J.M. Dehydroepiandrosterone sulfate directly activates protein kinase C-beta to increase human neutrophil superoxide generation. Mol. Endocrinol. 2010, 24(4):813-821.
32. Redeuilh G., Secco C., Baulieu E. The use of the biotinyl estradiol-avidin system for the purification of " nontransformed" estrogen receptor by biohormonal affinity chromatography. J. Biol. Chem. 1985, 260:3996-4002.
33. Simoncini T., Mannella P., Fornari L., Varone G., Caruso A., Genazzani A.R. Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology 2003, 144:3449-3455.
34. Trivedi D.P., Khaw K.T. Dehydroepiandrosterone sulfate and mortality in elderly men and women. J. Clin. Endocrin. Metab. 2001, 86:4171-4177.
35. Webb S.J., Geoghegan T.E., Prough R.A., Michael Miller K.K. The biological actions of dehydroepiandrosterone involves multiple receptors. Drug Metab. Rev. 2006, 38:89-116.
36. Williams M.R., Ling S., Dawood T., Hashimura K., Dai A., Li H., Liu J.P., Funder J.W., Sudhir K., Komesaroff P.A. Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs. J. Clin. Endocrin. Metab. 2002, 87:176-181.
37. Zettner A. Principles of competitive binding assays (saturation analysis). Clin. Chem. 1973, 19:699-705.
38. Zysk J., Gaylinn B., Lyons C., Johnson B., Eppler C., Baumbach W., Thorner M. Purification of the growth hormone releasing hormone receptor with a C-terminal, biotinylated affinity ligand. Biochem. Biophys. Res. Commun. 1996, 221:133-139.